ResearcherOhio State UniversityActive in the last 2 years

Harrison Kim

Provisional: name at one institution (moderate confidence)As of 13 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 0
Pancreatic cancer trials: 2 (principal investigator on 2)
Pancreatic cancer grants: 0
Collaborators: 0

Papers, trials and grants by year

2020: 1 trial · 2021: none · 2022: none · 2023: none · 2024: 1 trial

Trials 2

DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Principal investigator NCT06173310 ↗
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response Principal investigator NCT04588025 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.